HealthQuest Capital

Type

Venture Capital

Status

Active

Location

Redwood City, United States

Total investments

47

Average round size

34M

Portfolio companies

29

Rounds per year

4.27

Lead investments

17

Follow on index

0.38

Exits

9

Stages of investment
Private EquityLate Stage Venture
Areas of investment
BiotechnologyInformation TechnologyHealth CareHealth DiagnosticsWellnessMedical DeviceMedicalPharmaceuticalmHealthClinical Trials

Summary

The venture was found in North America in United States. The main department of described VC is located in the Menlo Park.

The high activity for fund was in 2019. The fund is generally included in 2-6 deals every year. The top amount of exits for fund were in 2019. The common things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this HealthQuest Capital performs on 15 percentage points less the average number of lead investments. Considering the real fund results, this VC is 34 percentage points more often commits exit comparing to other organizations.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the HealthQuest Capital, startups are often financed by Sofinnova Investments, BioStar Ventures, Aisling Capital. The meaningful sponsors for the fund in investment in the same round are Aisling Capital, Safeguard Scientifics, Polaris Partners. In the next rounds fund is usually obtained by Silicon Valley Bank, Smith & Nephew, Safeguard Scientifics.

Besides them, we counted 5 critical employees of this fund in our database.

The fund has specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Medical, Health Care. Among the various public portfolio startups of the fund, we may underline Ajax Health, Magnolia Medical Technologies, Trice Medical

Show more

Investor highlights

Industry focus
HealthcareMedtech

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
USD 675000000
Fund raised date
2023-05-17

Analytics

Total investments
47
Lead investments
17
Exits
9
Rounds per year
4.27
Follow on index
0.38
Investments by industry
  • Health Care (42)
  • Medical Device (26)
  • Health Diagnostics (18)
  • Medical (11)
  • Biotechnology (8)
  • Show 30 more
Investments by region
  • United States (40)
  • United Kingdom (3)
  • Canada (3)
  • South Korea (1)
Peak activity year
2019
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
12
Avg. valuation at time of investment
95M
Group Appearance index
0.87
Avg. company exit year
12
Avg. multiplicator
2.94

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Ajax Health 18 Jun 2019 Health Care, Medical Device, Clinical Trials Late Stage Venture 15M United States, California
Inbound Health 20 Sep 2023 Early Stage Venture 30M United States, Minnesota, Minneapolis

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.